Gracell Biotechnologies

Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
M&A
AstraZeneca
Gracell Biotechnologies
Bristol Myers Squibb
Rayze Bio
Roche
IPO tracker: 2021 gets started with a flurry of new offerings
Endpoints
Mon, 01/25/21 - 10:43 am
IPOs
Sana Biotechnology
Sensei Biotherapeutics
Bolt Biotherapeutics
Immunocore
Terns Pharmaceuticals
Pharvaris
Vor Biopharma
Adagene
NexImmune
Biophytis
Gracell Biotechnologies
Cullinan Oncology